The effect of a self-sampling device for human papillomavirus (HPV) test on the women's participation to cervical cancer screening in Italy

Conditions

Cervical cancer prevention Cancer Malignant neoplasm of the cervix

Jane R. Montealegre, Matthew L. Anderson, Susan G. Hilsenbeck, Elizabeth Y. Chiao, Scott B. Cantor et al. (13 authors)

Trials2020-10-2114 citations

Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.

Brewer N, Bartholomew K, Maxwell A, Grant J, McPherson G, Wihongi H, Bromhead C, Scott N, Crengle S, Cunningham C, Douwes J, Potter JD.

2019-12-098 citations

10.1186/s12885-019-6401-y

Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.

Tranberg M, Bech BH, Blaakær J, Jensen JS, Svanholm H, Andersen B.

2018-03-0970 citations

10.1186/s12885-018-4165-4

Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program

Mette Tranberg, Bodil Hammer Bech, Jan Blaakær, Jørgen Skov Jensen, Hans Svanholm et al. (6 authors)

BMC Cancer2016-11-0321 citations

10.1186/s12885-016-2859-z

Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia.

Sultana F, English DR, Simpson JA, Brotherton JM, Drennan K, Mullins R, Heley S, Wrede CD, Saville M, Gertig DM.

2014-03-1924 citations

10.1186/1471-2407-14-207

Interventions

Control 1: standard recall letter to perform Pap test at the clinic Control 2: standard recall letter to perform Pap test at the clinic Intervention 1: direct mailing of the self sampling device at ho

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All women (aged 35 - 64 years) non-responding to the screening invitation in the previous year and eligible for recall

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
Performing a test (HPV or Pap) within 3 months since the recall letter.	—

Secondary

Measure	Time frame
How many of the women performing a test after the intervention were never-screened or under-screened (last Pap test more than 3 years before)?	—

Countries

Italy

Outcome results

None listed